Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a Locations section with new study sites in Illinois, Oregon, Pennsylvania, Tennessee, New South Wales, Victoria, Ontario, Barcelona, and Navarre. Updated the revision to v3.3.3 and removed older related topics such as MedlinePlus Genetics and the term 'Multiple myeloma' from related topics.SummaryDifference1%

- Check20 days agoChange DetectedAdded related topics links for Multiple myeloma and MedlinePlus Genetics to the page, providing extra context without altering core study details or workflow. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoChange DetectedRemoved related topics: Multiple myeloma and MedlinePlus Genetics from the page. The main study details remain unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now includes the condition 'Multiple myeloma' and a MedlinePlus Genetics related topics link. The site revision was updated from v3.3.1 to v3.3.2.SummaryDifference0.2%

- Check41 days agoChange DetectedEditorial update to the Publications section clarifies that entries are auto-filled from PubMed and may not relate to the study. The Revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page no longer displays the government funding status notice and removes the 'Multiple myeloma' and 'MedlinePlus Genetics' related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.